<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>38(14)</volume><submitter>Augello M</submitter><pubmed_abstract>In this prospective longitudinal study, we evaluated the durability of humoral responses to SARS-CoV-2 mRNA booster vaccination in 93 people with HIV, exploring the possible role of T-cell dysfunction and inflammaging biomarkers in predicting antibody waning. We found that, despite a negligible influence of the inflammaging milieu, low CD4/CD8 ratio and CD4+CD127+ percentage as well as high CD8+CD38+CD45RO+ percentage are associated with faster antibody waning, in turn contributing to our understanding of the determinants of COVID-19 vaccine-elicited immune response in this population.</pubmed_abstract><journal>AIDS (London, England)</journal><pagination>1987-1990</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11556865</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV.</pubmed_title><pmcid>PMC11556865</pmcid><pubmed_authors>Rovito R</pubmed_authors><pubmed_authors>Augello M</pubmed_authors><pubmed_authors>Tincati C</pubmed_authors><pubmed_authors>Santoro A</pubmed_authors><pubmed_authors>Bono V</pubmed_authors><pubmed_authors>Marchetti G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV.</name><description>In this prospective longitudinal study, we evaluated the durability of humoral responses to SARS-CoV-2 mRNA booster vaccination in 93 people with HIV, exploring the possible role of T-cell dysfunction and inflammaging biomarkers in predicting antibody waning. We found that, despite a negligible influence of the inflammaging milieu, low CD4/CD8 ratio and CD4+CD127+ percentage as well as high CD8+CD38+CD45RO+ percentage are associated with faster antibody waning, in turn contributing to our understanding of the determinants of COVID-19 vaccine-elicited immune response in this population.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2025-04-26T06:08:08.951Z</modification><creation>2025-04-06T11:45:56.209Z</creation></dates><accession>S-EPMC11556865</accession><cross_references><pubmed>39474654</pubmed><doi>10.1097/QAD.0000000000004010</doi></cross_references></HashMap>